Ledger.Open graph →
SEC Form D · filed December 13, 2017

Coherus BioSciences, Inc

Offering
$6.8M
Sold
$6.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
REDWOOD CITY, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Mary T. Szela · Redwood City, CADirectorPeter K. Watler, Ph.D · Redwood City, CAExecDennis M. Lanfear · Redwood City, CAExec · DirectorAlan C. Herman · Redwood City, CAExecBarbara K. Finck, M.D · Redwood City, CAExecV. B. Lawlis · Redwood City, CADirectorMats J. Wahlstrom · Denver, CODirectorAli J. Satvat · Menlo Park, CADirectorJoseph Hanna · Charleston, SCExecZaid Ashai · Boston, MADirectorKim E. Armor · Washington, Washington, D.C.ExecAugust J. Troendle, M.D · Chincinnati, OHDirectorJean Frederic J. Viret, Ph.D · Redwood City, CAExecJames I. Healy, M.D., Ph.D · Redwood City, CADirectorChristos B. Richards · Redwood City, CADirectorHenri-Claude S. Bailly · Boston, MAExec · DirectorJames S. Eisenstein · Boston, MAExecRobert E. Pantano · Boston, MAExec · DirectorJessica Marion · New York, NYDirectorJacques Nasser · Philadelphia, PAExecV. B. Lawlis · Redwood City, CADirectorMats J. Wahlstrom · Redwood City, CADirectorAugust J. Troendle, M.D · Cincinnati, OHDirectorJean Frederic J. Viret, Ph.D · Redwood City, CAExecJames I. Healy, M.D., Ph.D · Menlo Park, CADirectorChristos B. Richards · Los Angeles, CADirectorAli J. Satvat · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗